This panel discussion includes orthopedic companies with varying types of enabling and digital technologies. The group will explore questions such as: What are the uses and benefits of the technology today? How will the technology advance over time? How will data be captured and utilized to improve technology, surgical techniques and patient outcomes? What will it take to gain greater adoption in orthopedics?
The logistical management of medical devices preoperatively, intraoperatively and postoperatively has remained unchanged for decades. Learn how automating these processes produces tremendous value for all stakeholders.
Tantalum (Ta) metal has the potential to revolutionize next-generation materials for orthopedic applications. Croom Medical and Global Advanced Metals (GAM) have partnered to establish a new Ta-based medical device manufacturing capability. This presentation will review and summarize the results of the demonstration device designs alongside initial testing data from the manufactured Ta parts produced from GAM’s high-purity powders.
2D barcode requirements for UDI pertaining to EU MDR compliance is on the horizon for most instrument manufacturers. The process involves the validation of the verifier unit, the review and grouping of affected materials and the internal validation of existing part marking processes. In addition, each material and surface treatment has its own critical parameters that must be considered. Metal Craft will share its experience and overview of the implementation.
Companies must reach young minds and educate them on the benefits of working in manufacturing, including high levels of job satisfaction and earning potential. MB&A plans to make trade skill options more accessible through outreach, partnerships and apprenticeships. The efforts will include competency evaluations and a potential to gain certification.
Surface technologies play an integral role in the success of joint replacement implants, and orthopedic device companies are launching new coatings with greater biological acceptance. In this session, orthopedic companies discuss R&D efforts in implant coating and market forces driving new coatings and materials.
When fully leveraged, additive manufacturing and robotics can produce patient-optimized implants that are precisely inserted. The adoption of these technologies in tandem can lead to personalized joint replacement procedures that achieve clinical benefit, decrease inventory costs and increase surgical efficiencies.
This panel discussion brings together orthopedic technology leaders to discuss optimizing teams, overcoming complex challenges and collaborating in a post-pandemic world.
In this presentation, you will learn practical tools and ideas to help you cope — and even thrive — amid constant change. Find out how to manage your own energy and build the optimism, empathy and confidence needed to successfully navigate the craziness.
The growing use of wireless orthopedic devices, the electronic exchange of device-related health information and increases in the volume and scope of recent cyberattacks in the healthcare sector have ramped up FDA’s focus on medical devices.
